申请人:Millennium Pharmaceuticals, Inc.
公开号:US20170174704A1
公开(公告)日:2017-06-22
This invention provides compounds of formula I and subsets thereof: wherein T, J, R, R
4
, R
q
, o, R
A
, and R
B
and subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, or T-cell mediated autoimmune disease.